Ellen C Keeley

7PUBLICATIONS
35CO-AUTHORS
Characterisation of biological macromoleculesMedical biotechnology diagnostics (incl. biosensors)PharmacogenomicsMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention.

|Jul 04, 2025
CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.

Rajiv C Patel, Cameron D Thomas, Joseph S Rossi

|Aug 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies.

Larisa H Cavallari, Craig R Lee, Francesco Franchi

|Jun 14, 2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.

Kayla R Tunehag, Cameron D Thomas, Francesco Franchi

|Feb 13, 2024
Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction.

Andrew P Stein, Jonathan Harder, Henry R Holmes

|Jun 10, 2023
Circulating Biomarkers in Coronary Microvascular Dysfunction.

Teja Chakrala, Roshni Prakash, Carlos Valdes

Pageof 2

Frequent Collaborators

4 joint publications

Dominick J Angiolillo

4 joint publications

Larisa H Cavallari

4 joint publications

Craig R Lee

3 joint publications

Francesco Franchi